D3A.0 — Benign carcinoid tumors

Not billable

Is D3A.0 billable?

No — D3A.0 is a non-billable header code. D3A.0 groups more specific codes and cannot be submitted on a claim. A valid ICD-10-CM code must be reported at the highest level of specificity available in its branch. Select one of the 21 billable codes beneath D3A.0.

Billable codes under this header

D3A.0 at a glance

Code	D3A.0
Description	Benign carcinoid tumors
Billable	No — header code
Code set	ICD-10-CM FY2027
Valid for encounters	October 1, 2026 – September 30, 2027

Use additional code — inherited from D3A

Report an additional code alongside D3A.0 to fully describe the condition. D3A.0 is sequenced first.

code to identify any associated endocrine syndrome, such as:
carcinoid syndrome (E34.00)

Excludes2 — not included here — inherited from D3A

The conditions below are not part of D3A.0, but a patient may have both at the same time. When documentation supports it, D3A.0 and the excluded code may both be reported.

benign pancreatic islet cell tumors (D13.7)

Code also — inherited from D3A

Two codes may be needed to describe the condition fully. Whether D3A.0 is sequenced first depends on the reason for the encounter.

any associated multiple endocrine neoplasia [MEN] syndromes (E31.2-)

What codes fall under D3A.0? (4)

How long has D3A.0 existed?

D3A.0 has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.

Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.

What other codes are in the D3A family? (1)

D3A.8Other benign neuroendocrine tumors